News Announcement

Panacea Biotec: Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015

We would like to inform you that the Company has received on March 06 2026 a Demand Order dated March 01 2026 from the Office of Deputy Commissioner of Income Tax imposing demand on account of disallowances of certain expenditures resulting into demand aggregating to ~Rs.10.23 Crore w.r.t. Assessment Year 2016-17. Requisite details are given under disclosure attached herewith.

Disclaimer: This content is for information only and should not be considered investment advice or a recommendation.

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.